0001104659-24-048900.txt : 20240418 0001104659-24-048900.hdr.sgml : 20240418 20240418164412 ACCESSION NUMBER: 0001104659-24-048900 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240417 FILED AS OF DATE: 20240418 DATE AS OF CHANGE: 20240418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buchholz Richard CENTRAL INDEX KEY: 0001737133 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38468 FILM NUMBER: 24854814 MAIL ADDRESS: STREET 1: C/O INSPIRE MEDICAL SYSTEMS, INC. STREET 2: 9700 63RD AVENUE NORTH, SUITE 200 CITY: MAPLE GROVE STATE: MN ZIP: 55369 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inspire Medical Systems, Inc. CENTRAL INDEX KEY: 0001609550 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 261377674 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5500 WAYZATA BLVD STREET 2: SUITE 1600 CITY: GOLDEN VALLEY STATE: MN ZIP: 55416 BUSINESS PHONE: 763-957-5037 MAIL ADDRESS: STREET 1: 5500 WAYZATA BLVD STREET 2: SUITE 1600 CITY: GOLDEN VALLEY STATE: MN ZIP: 55416 4 1 tm2412174-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-04-17 0 0001609550 Inspire Medical Systems, Inc. INSP 0001737133 Buchholz Richard C/O INSPIRE MEDICAL SYSTEMS, INC. 5500 WAYZATA BLVD., SUITE 1600 GOLDEN VALLEY MN 55416 0 1 0 0 Chief Financial Officer 1 Common Stock 2024-04-17 4 S 0 15000 230.03 D 28271 D Common Stock 2024-04-17 4 G 0 500 0 D 27771 D Common Stock 2024-04-17 4 G 0 125 0 A 1350 I By daughter Common Stock 2024-04-17 4 G 0 125 0 A 1350 I By son Common Stock 2024-04-17 4 G 0 125 0 A 1350 I By son Common Stock 2024-04-17 4 G 0 125 0 A 1350 I By son Reflects shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.00 to $230.82. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Bryan Phillips, Attorney-in-Fact for Richard Buchholz 2024-04-18